share_log

ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND WARRANT AMENDMENTS

ARCPOINT ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT AND WARRANT AMENDMENTS

ARCP轉型宣佈完成定向增發及認股權修正
GlobeNewswire ·  08/01 02:48

Not for Dissemination in the United States or through U.S. Newswire Services

本資訊不適用於美國或通過美國新聞電線服務發佈。

Greenville, South Carolina, July 31, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the "Company" or "ARCpoint") is pleased to announce that it has closed its previously announced non-brokered private placement (the "Offering") for gross proceeds of $1,004,175, through the sale of 13,389,000 class A subordinate voting shares of the Company (each, a "Share") at a price of $0.075 per Share.

南卡羅來納州格林維爾,2024年7月31日,(全球新聞網)——ARCpoint股份公司(TSXV:ARC)(“公司”或“ARCpoint”)非常高興地宣佈,已收盤其先前宣佈的定向增發(“發行”),以公司的13,389,000股A類下級表決股(每股股份稱爲“Share”)的價格爲0.075美元/份,總募集資金爲1,004,175 美元。

The net proceeds from the Offering will be used for operational expenses and other general corporate purposes including increasing investor awareness, investor relations and marketing expenses.

發行所得淨額將用於業務支出和其他一般企業目的,包括提高投資者認識度、投資者關係和市場營銷支出。

In connection with the closing of the Offering the Company issued 670,900 finder's shares (the "Finder's Shares"), 1,013,900 finder's warrants (the "Finder's Warrants") and paid a cash commission of $60,834 to certain arm's length finders, including Canaccord Genuity Corp. and Haywood Securities Inc. Each Finder's warrant entitles the holder thereof to purchase one Share (a "Finder's Warrant Share") at a price of $0.075 per Finder's Warrant Share until July 31, 2026.

與發行收盤有關,公司發行了670,900股尋找者股票(“尋找者股票”),1,013,900股尋找者認股權證(“尋找者認股權證”),並向某些法律風險參與者(包括加拿大國信證券和海伍德證券公司)支付了60,834美元的現金佣金。每個尋找者權證的持有人有權以每個尋找者權證的價格0.075美元購買一股股票(“尋找者權證股份”),有效期至2026年7月31日。

The Offering remains subject to final acceptance from the TSX Venture Exchange (the "TSXV"). All securities issued in connection with the Offering are subject to a four-month hold period from the closing date under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.

發行仍需獲得TSX Venture Exchange(“TSXV”)的最終接受。與發行有關的所有證券均受加拿大證券法適用的四個月持有期限制,並受適用於加拿大以外法域的證券法規的其他限制。

The securities described herein have not been, and will not be, registered under the U.S. Securities Act, as amended, or any state securities laws, and accordingly, may not be offered or sold within the United States or the US persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.

所述證券未根據《美國證券法》或州證券法註冊,因此可能不得在美國或美國人內部以外的地方提供或出售,除非遵守《美國證券法》的登記要求和適用州證券法規的要求或依據它們的豁免規定。本新聞稿不構成在任何司法管轄區內出售或邀請購買任何證券的要約。

Warrant Amendment

權證修改

The Company is also pleased to announce that it intends to extend the expiry date of 5,000,000 Share purchase warrants (the "Warrants") from December 31, 2024 to December 31, 2026 (the "Extension"). On December 16, 2021 ARCpoint Group LLC ("ARCpoint Group") issued 10,000 warrants (the "ARCpoint Warrants") to ARCpoint Group security holders. Following the completion of the Company's reverse takeover transaction on October 21, 2022, the ARCpoint Warrants were exchanged for the Warrants. Each Warrant entitles the holder thereof to acquire a Share at a price of $0.16 per Share. The Extension remains subject to receipt of TSXV approval.

該公司還計劃將5,000,000股購股權證(“權證”)的到期日期從2024年12月31日延長至2026年12月31日(“延期”)。2021年12月16日,ARCpoint Group LLC(“ARCpoint Group”)向ARCpoint Group證券持有人發行了10,000份權證(“ARCpoint權證”)。在公司於2022年10月21日完成反向收購交易後,ARCpoint權證被交換爲權證。每個權證使持有人有權以每股0.16美元的價格購買一股股票。該延期仍需獲得TSXV的批准。

About ARCpoint Inc.

關於ARCpoint Inc.

ARCpoint is a leading US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing, corporate wellness programs, and employment and background screening, among other services. The Company is based in Greenville, South Carolina, USA. ARCpoint Franchise Group LLC, formed under the laws of the state of South Carolina in February 2005, is the franchisor of ARCpoint Labs and supports over 130 independently owned locations. ARCpoint sells franchises to individuals throughout the United States and provides support in the form of marketing, technology and training to new franchisees. ARCpoint Corporate Labs LLC develops corporate-owned labs committed to providing accurate, cost-effective solutions for customers, businesses and physicians. AFG Services LLC serves as the innovation center of the ARCpoint group of companies as it builds a proprietary technology platform and a physician network to equip all ARCpoint labs with best-in-class tools and solutions to better serve their customers. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing and physician services for ARCpoint franchise labs and other clients.

ARCpoint是一家領先的美國特許經營系統,提供藥物測試,酒精篩查,DNA和臨床實驗室測試,企業健康計劃,就業和背景調查等服務。該公司總部位於美國南卡羅來納州格林維爾。成立於2005年2月的ARCpoint特許經營集團LLC是ARCpoint Labs的特許經營權人,並支持超過130個獨立擁有的地點。ARCpoint向美國各地的個人銷售特許經營權,併爲新特許經營者提供營銷,技術和培訓方面的支持。ARCpoint Corporate Labs LLC成立了企業擁有的實驗室,致力於爲客戶,企業和醫生提供準確,具有成本效益的解決方案。AFG Services LLC作爲ARCpoint公司集團的創新中心正在打造一款專有的技術平台和醫生網絡,以爲所有ARCpoint實驗室配備最佳工具和解決方案,以更好地服務他們的客戶。此外,平台還將數字化和流程化管理功能,如材料採購,合規性,賬單和醫生服務提供給ARCpoint特許經營實驗室和其他客戶。

For more information, please contact:

更多信息,請聯繫:

ARCpoint Inc.
Jason Tong, Chief Financial Officer
Phone: (604) 889-7827
E-mail: invest@arcpointlabs.com

ARCpoint Inc.
財務總監Jason Tong
電話:(604) 889-7827
電子郵件:invest@arcpointlabs.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

TSX Venture Exchange及其監管服務提供者(根據該交易所的政策所定義的該術語)均不承擔此新聞稿的充分性或準確性責任。

Forward-Looking Information

前瞻性信息

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things, Company's use of proceeds from the Offering and expectations regarding the receipt of the necessary regulatory approvals for the Offering and the Extension.

本公告包含某些可能構成適用於加拿大證券法的前瞻性信息和說明。前瞻性陳述涉及未來事件或未來業績,並反映公司管理層對未來事件的期望或信任。一般而言,前瞻性陳述和信息可以通過使用前瞻性術語(如“計劃”或“預測”)或這些詞語和短語的變化以及表明某些行動,事件或結果“可能”,“可能”,“應該” ,“將”或“發生”的陳述來識別。這些信息和這些陳述,以下簡稱“前瞻性陳述”,不是歷史事實,是截至本新聞發佈日期的聲明,幷包括但不限於,關於未來計劃的討論,估計和預測以及關於管理層對,公司利用發行所得的資金的預期和意圖以及關於發行和延期所需的必要監管批准的預期和意圖的聲明。

These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things, that the Company will not receive the necessary regulatory approvals in respect of the Offering or the Extension and that the use of proceeds from the Offering may differ from management's expectations.

這些前瞻性陳述涉及衆多風險和不確定性,實際結果可能與任何前瞻性陳述中暗示的結果有所不同。這些風險和不確定性包括但不限於:公司將無法獲得有關發行或延期的必要監管批准,以及發行所取得的收益的使用可能與管理層的預期不同。

In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, that the Company will receive the necessary regulatory approvals in respect of the Offering and the Extension and use the gross proceeds from the Offering as currently contemplated.

在本新聞稿中作出前瞻性陳述時,公司已經應用了幾個實質性假設,包括但不限於,公司將獲得與發行或延期相關的必要監管批准,並按照當前預期使用發行所募集的總額。

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.

儘管公司管理層試圖確認可能導致實際結果與前瞻性聲明或前瞻性信息不同的重要因素,或意圖,或預估,但可能還存在導致結果不如預期、估計或預期的其他因素。因此,讀者不應就前瞻性聲明和前瞻性信息做出過多的依賴。讀者應被告知,依賴這種信息可能不適合其他用途。該公司不承諾更新任何已被納入其中的前瞻性聲明、前瞻性信息或財務展望,除非按照適用的證券法規。我們尋求安全港。


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論